They do not constitute endorsement, promotion, or any suggestion that this product is approved, safe, or intended for human or animal use
severe or persistent upper abdominal pain should prompt urgent medical assessment [10] [11] Dehydration and acute kidney injury (AKI): gastrointestinal fluid losses can lead to dehydration, which may precipitate AKI, particularly in those with pre-existing renal impairment or those taking nephrotoxic medicines Delayed gastric emptying: this may affect the absorption of orally administered medicines, including contraceptive pills and thyroid replacement therapy [11] Injection site reactions: redness, bruising, or discomfort at the subcutaneous injection site Heart rate changes: increases in resting heart rate have been noted with GLP-1 class agents [14] [15] Hypoglycaemia: particularly if used alongside insulin or sulphonylureas Potential pancreatitis risk: a class concern with GLP-1 receptor agonists
Open COA Lookup View Specimen COA COA records are available to signed-in account holders when batch documentation is released
Clinical Benefits Four peptides working together create therapeutic effects greater than individual components, providing comprehensive regenerative support across multiple systems
No changes in expression of tight junction proteins or bloodbrain barrier permeability in azoxymethane-induced experimental acute liver failure
